Curating from trusted global sources…
22 briefings · “m a”
A24s new series stacks corporate power, marriage, and a mess of NDAs, and it turns legal process into drama.
A July 18 festival stunt turns into a staged shutdown attempt, then ends with the troupe joining Limp Bizkit.
A CVPR highlight proposes a safer way to justify split-second choices, and executives should care about explainability.
The Journey keyboardist criticizes Springsteen’s political activism and insists artists should “do your art.”
A gum-disease bacterium appears to spark inflammation that turns valve tissue into bone-like calcium makers, at least in early studies.
What sounds like a harmless caffeine comfort blanket ran into evidence of cardiovascular harm across higher intakes.
A new Earth-like discovery sharpens the roadmap for future telescopes, funding, and standards for what “habitable” really means.
What looks like a simple streaming bet is actually a $22 billion corporate reshuffle with board and regulatory gravity.
The IPO lands on Nasdaq as critics question Musk’s near-absolute ownership, and the filings force boards to look hard.
A small modular nuclear startup cleared the self-sustaining line. Regulators and investors now shift to the next proof point.
